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Abstract
Background: Surgical site infections (SSI) represent a considerable burden for healthcare systems. They are largely
preventable and multiple interventions have been proposed over past years in an attempt to prevent SSI.
We aim to provide a position paper on Operative Room (OR) prevention of SSI in patients presenting with intra-
abdominal infection to be considered a future addendum to the well-known World Society of Emergency Surgery
(WSES) Guidelines on the management of intra-abdominal infections.
Methods: The literature was searched for focused publications on SSI until March 2019. Critical analysis and grading
of the literature has been performed by a working group of experts; the literature review and the statements were
evaluated by a Steering Committee of the WSES.
Results: Wound protectors and antibacterial sutures seem to have effective roles to prevent SSI in intra-abdominal
infections. The application of negative-pressure wound therapy in preventing SSI can be useful in reducing
postoperative wound complications.
It is important to pursue normothermia with the available resources in the intraoperative period to decrease SSI
rate.
The optimal knowledge of the pharmacokinetic/pharmacodynamic characteristics of antibiotics helps to decide
when additional intraoperative antibiotic doses should be administered in patients with intra-abdominal infections
undergoing emergency surgery to prevent SSI.
Conclusions: The current position paper offers an extensive overview of the available evidence regarding surgical
site infection control and prevention in patients having intra-abdominal infections.
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Background
Surgical site infections (SSI) are a common type of
healthcare-associated infections and frequent complica-
tion of hospitalization, responsible for prolonged hospital
stay, increased intensive care unit admissions, hospital
readmissions after surgery, significantly increased costs
(1300–5000 USD per SSI), and delays to adjuvant systemic
therapy; they occur in 2 to 5% of patients undergoing sur-
gery in the USA [1–3].
Approximately 160,000 to 300,000 SSI are diagnosed
and treated every year and represent a considerable bur-
den for healthcare systems in terms of re-operation,
increased post-surgical pain, poor wound healing, pro-
longed hospital stay, cosmetic appearance, and decreased
quality of life [4–7].
SSI has also been shown to be an independent risk fac-
tor in the development of incisional hernia [8].
The incidence of all types of SSI following abdom-
inal surgery can reach 14% of all hospital-acquired in-
fections and the most common form is the incisional
superficial SSI, which is often the first to appear and
is easy to diagnose [9].
While more data are available from Western health-
care settings, SSI was the leading cause of hospital-
acquired infection in a systematic review of studies in
low- and middle-income countries [10].
They also a result in deleterious softer endpoints such
as patient psychosocial distress, loss of income, and de-
creased productivity [1–3].
Multiple interventions have been proposed and
employed over the past decades in an attempt to prevent
SSI. These include skin cleansing protocols, hair removal,
the maintenance of intraoperative normothermia, the pre-
operative antimicrobial prophylaxis administration, the
use of plastic adhesive skin barriers, the high flow oxygen
supplementation, the wound protection, the sterility of in-
struments, the bowel preparation, the length of the inci-
sion, and the delayed primary incision closure [11–15].
The development of SSI is multifactorial, and it may
be related to patient’s risk factors such as age, comorbid-
ities, smoking habit, obesity, malnutrition, immunosup-
pression, malignancies, and the class of contamination of
the wound [9, 16].
Emergency surgery is a risk factor for SSI because
many strong risk factors for SSI such as contaminated
and dirty wounds, prolonged duration of the operation,
patient comorbidities, and high American Society of
Anesthesiologists (ASA) score are commonly present in
this type of surgery. For these reasons, the World Society
of Emergency Surgery (WSES) developed a position paper
for the prevention of SSI in the operative room (OR).
A panel of international experts discussed statements
based on predetermined research questions and the re-
sults of related systematic literature reviews.
The literature search found few articles focused on SSI
and emergency surgery; consequently, most of the
reviewed studies considered the incidence of SSI in
elective surgery because of the lack of valid data from an
emergency setting. This is a consequence of the diffi-
culty to conduct a good-quality study in an emergency
environment: the workload is often intermittent and un-
predictable, patient case-mix is heterogeneous with a
wide variety of concomitant problems and severity of
initial diagnosis; moreover, the emergency environment
poses many barriers and obstacles to patient recruitment
and data collection, and this has implications particularly
for the staffing of prospective trials.
Considering all these limitations, we cannot ignore the
potential benefit from using some devices and equip-
ment or adopting some simple strategies in emergency
surgery to decrease the incidence of SSI.
This position paper aims to provide recommendations
on OR prevention of SSI in patients with intra-abdominal
infections to be an addendum to the WSES Guidelines on
the management of intra-abdominal infections.
Materials and methods
In July 2018, the Scientific Board of the WSES, the
President of the Society and the President of the 5th
World Congress of the WSES decided to prepare a pos-
ition paper on OR prevention of SSI in patients with
intra-abdominal infections in the emergency setting.
The Presidents and ten members of the Scientific
Secretariat (SS) agreed on 11 key topics to develop in
the position paper (Table 1); nine international experts,
members of the WSES Board, were chosen as Steering
Committee (SC).
Each topic was developed by members of the SS: the
SC and the Presidents supervised every step of literature
search, selection, and the final work.
The SS provided the electronic search in PubMed and
EMBASE databases, according to specific keywords for
each question as you can see in the Appendix 1 without
time or language restrictions.
Each expert followed the PRISMA methodology in the
selection of papers to consider for review: meta-analyses
of randomized controlled trials, randomized control trials,
prospective studies, observational studies, large case series,
and systematic reviews were included in this study.
Each SS member developed a focused draft and a
variable number of statements. Each statement has been
evaluated according to the Grading of Recommendations,
Assessment, Development and Evaluation (GRADE) [17]
summarized in Table 2.
The provisional statements and the supporting literature
were reviewed by all SS members and the Presidents, dis-
cussed with the SC members by email/call conferences and
modified if necessary.
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Table 1 Summary of statements
Main topics Statements
1) How to close a surgical incision? Statement 1.1:
There is no significant difference in terms of SSI incidence and length of
hospital stay between patients in which the skin is sutured by continuous
versus interrupted stitches (GoR 1B)
Statement 1.2:
Superficial wound dehiscence is lower in subcuticular continuous suture
versus interrupted stitches. (GoR 1B)
Statement 1.3:
The use of steri-strips doesn't reduce the incidence of SSI
2) Coated sutures: are they useful? Statement 2:
Triclosan-coated sutures significantly reduce SSI prevalence compared with
the non-coated sutures (GoR1B)
3) What is the role of intraoperative intraperitoneal irrigation vs topic
wound lavage with antibiotic solutions to prevent surgical site infections?
Statement 3:
There are insufficient data to to support the role of intraperitoneal the role of
intraperitoneal or topic wound irrigation with antibiotics in preventing SSI
4) Could wound irrigation with saline and/or povidone iodine solution be
useful to prevent surgical site infections?
Statement 4:
There are insufficient data to determine the role of saline or povidone
solution irrigation of incisional wounds before closure to prevent SSI
(GoR 2B).
5) Are wound protector devices useful? Statement 5.1:
The use of wound protectors has protective effects in reducing incisional SSI
(GoR 1A);
Statement 5.2:
The use of dual-ring constructed wound protectors appears to be superior
to single-ring devices in preventing SSI (GoR1B).
6) Are sterile surgical drapes useful? Statement 6:
There is no evidence that plastic adhesive incise drapes with or without
antimicrobial properties are useful to decrease SSI (GoR 2C).
7) To drain or not to drain in closing surgical incision? Statement 7:
There are insufficient data to determine the role of the use of subcutaneous
drainage of incisional wounds before closure to prevent SSI in high-risk patients
(GoR 2B)
8) When is double gloving recommended? When is changing gloves
recommended during an operation?
Statement 8.1:
There are insufficient data to determine the role of double gloving to prevent
SSI (GoR 2C).
Statement 8.2:
The mechanical resistance of latex gloves depends on the duration of wear. It
may be beneficial for surgical team members and their protection to change
gloves at certain intervals during surgery (GoR 2C).
9) Is negative-pressure wound dressing useful to prevent surgical site
infections?
Statement 9:
The application of negative-pressure wound therapy in preventing SSI may be
effective in reducing postoperative wound complications and it may be an
option especially in patients with a high risk of SSI
(GoR 2C)
10) Is intraoperative normothermia useful to prevent surgical site
infections?
Statement 10.1:
Intraoperative normothermia decreases the rate of SSI (GoR 1A).
Statement 10.2:
The use of active warming devices in operating room is useful to keep
normothermia and reduce SSI (GoR 1B)
11) Is perioperative supplemental oxygen effective to reduce surgical
site infections?
Statement 11:
Perioperative hyperoxygenation does not reduce SSI (GoR 2B)
12) Leaving the skin open for delayed primary closure can reduce SSI? Statement 12.1:
Delayed primary skin closure may reduce the incidence of SSI (GoR 2C)
Statement 12.2:
Delayed primary closure of a surgical incision is an option to take into
consideration in contaminated abdominal surgeries, in patients
with high risk of SSI (GoR 2C)
13) When should additional antibiotic dose be administered
intraoperatively?
Statement 13:
Optimal knowledge and use of the pharmacokinetic/pharmacodynamic
characteristics of antibiotics are important to evaluate when additional
antibiotic doses should be administered intraoperatively in patients with
intra-abdominal infections undergoing emergency surgery (GoR 1C)
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The designated member of SS presented the state-
ments to SC along with the grade of recommendation
(GoR) and the literature supporting each statement.
Clinicians and surgeons must be aware that the present
position paper should be considered as an adjunctive tool
for decision and management, but they do not substitute
for the clinical judgment for individual patients.
Results
How to close a surgical incision?
Statement 1.1: There is no significant difference in terms of
SSI incidence and length of hospital stay between patients
in which the skin is sutured by continuous versus
interrupted stitches (GoR 1B).
Statement 1.2: Superficial wound dehiscence is lower in
subcuticular continuous suture versus interrupted stitches
(GoR 1B).
Statement 1.3: The use of steri-strips or tissue adhesives
doesn't reduce the incidence of SSI (GoR 1B).
The method of skin closure may have a role in
preventing the development of SSI. Compared with
interrupted sutures, continuous sutures can provide a
better seal preventing the exogenous bacterial invasion
of the surgical wound [16].
However, a continuous tightly pulled suture can stran-
gulate the wound edges [18, 19].
Many published trials have demonstrated the benefit
of skin closure by subcuticular interrupted sutures com-
pared with conventional skin stapling in different surgi-
cal scenarios [9, 16, 17].
On the other hand, very few papers have been designed
to investigate differences in the outcome when the skin is
closed by continuous or by interrupted sutures.
In a Cochrane meta-analysis [19] published in 2014
and focused on the impact that different methods of skin
closure could have on superficial SSI, superficial wound
dehiscence, and length of hospital stay, only five RCTs
comparing continuous versus interrupted sutures were
identified. The five RCTs included a total of 827 partici-
pants undergoing abdominal or groin operations (non-
obstetric surgery) [19–23]. Most of the enrolled patients
were children or adolescents, and appendectomy was the
most performed surgery.
Comparisons were made irrespectively of the material
of the sutures. From this meta-analysis, no statistically
significant differences were found between the two
methods of suture regarding the prevalence of superficial
SSI (RR 0.73; 95% CI 0.40 to 1.33) and length of hospital
stay. However, a lower rate of superficial wound dehis-
cence was recorded in the continuous suture group (RR
0.08; 95%, CI 0.02 to 0.35).
It should be noted that in these trials the continu-
ous skin suture groups received absorbable subcuticu-
lar sutures, while the interrupted skin suture groups
received non-absorbable transcutaneous sutures. The
non-absorbable sutures were removed 7 to 9 days
after surgery, which is generally considered to be a
suitable time for removal of sutures. The removal of
sutures was not necessary for the absorbable subcuti-
cular continuous suture group. The suture material
used in the continuous suture groups was 4-0 poligle-
caprone and 4-0 polyglactin [22, 23].
This kind of sutures retains approximately 50 to 75%
of their original tensile strength after 1 week in situ. This
extra support for the wound after 1 week may be the
main reason for the difference between the continuous
suture group and the interrupted suture group regarding
the development of superficial wound dehiscence [19].
Table 2 Grading of Recommendations, Assessment, Development and Evaluation (GRADE). RCTs randomized controlled trials
Grade of recommendation Quality of supporting evidence Implications
1A Strong recommendation, high-quality
evidence
RCTs without important limitations or overwhelming
evidence from observational studies
Strong recommendation, applies to most patients
in most circumstances without reservation
1B Strong recommendation, moderate-
quality evidence
RCTs with important limitations (inconsistent results,
methodological flaws, indirect analyses or imprecise
conclusions) or exceptionally strong evidence from
observational studies
Strong recommendation, applies to most patients
in most circumstances without reservation
1C Strong recommendation low-quality
or very low-quality evidence
Observational studies or case series Strong recommendation but subject to change
when higher quality evidence becomes available
2A Weak recommendation high-quality
evidence
RCTs without important limitations or overwhelming
evidence from observational studies
Weak recommendation, the best action may differ
depending on the patient, treatment
circumstances, or social values
2B Weak recommendation moderate-
quality evidence
RCTs with important limitations (inconsistent results,
methodological flaws, indirect or imprecise) or
exceptionally strong evidence from observational
studies
Weak recommendation, the best action may differ
depending on the patient, treatment
circumstances, or social values
2C Weak recommendation low-quality or
very low-quality evidence
Observational studies or case series Very weak recommendation; alternative treatments
may be equally reasonable and merit consideration
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Conclusions of the meta-analysis were that superficial
wound dehiscence may be reduced by using continuous
subcuticular sutures and that continuous or interrupted
skin closure does not have any impact on the develop-
ment of superficial SSI and on the length of hospital
stay. Due to the quality of the evidence, a high grade of
uncertainty remains.
In addition to the abovementioned meta-analysis, only
one study compared continuous versus interrupted skin
suture for abdominal surgery in a non-intra-abdominal
infection setting [24].
This review included 586 patients from a single
Japanese institution to compare the incidence of inci-
sional SSI after elective hepato-pancreatobiliary surgery
(HPB) by different methods of skin closure. The study
showed statistically significant efficacy of the subcuticular
continuous sutures to prevent incisional SSI in patients
undergoing HPB surgery (1.8% in the subcuticular continu-
ous suture group and 10.0% in the stapling group, P < 0.01).
However, the retrospective and single-institution design
substantially affect the evidence of the results.
Many papers showing the benefits of subcuticular
sutures versus stapling in terms of reduction of SSI and
wound dehiscence are available from the literature, but
unfortunately they were designed to compare inter-
rupted rather than continuous subcuticular sutures ver-
sus stapling, or they merge continuous and interrupted
techniques in a single group [9, 16, 25].
For these reasons, further well-designed RCTs with a
low risk of bias should be conceived to establish which
type of skin suturing provides better results.
A common practice in OR is to cover the closed
wound with adhesive steri-strips.
Custis et al. [26] carried out a prospective study to as-
sess whether the addition of adhesive strips to a wound
closed with buried interrupted subcuticular sutures im-
proves outcomes following wound closure. The study
enrolled 45 patients and showed that there was no sig-
nificant difference in the total patient assessment scale
score between the combination closure (14.0 [7.6]) and
sutures only (14.7 [7.6]) sides at 3 months (P = .39).
There was also no significant difference between the two
closure methods in terms of mean (SD) scar width (both
methods, 1.1 [0.8] mm, P = .89) at follow-up. There was
one case of wound dehiscence at a site that used adhe-
sive strips and two cases at sites without adhesive strips.
Three suture abscesses were documented at sites with
adhesive strips and six at sites without adhesive strips.
One patient had a spitting suture, which was not classi-
fied as an abscess; this event occurred at a site without
adhesive strips. There were no documented infections,
hematomas, or seromas. None of the adverse effects
were statistically significant between study arms. The au-
thors concluded that similar outcomes were observed
whether or not adhesive strips were applied in addition
to buried dermal sutures when performing cutaneous
surgical procedures and that the use of adhesive strips
cannot be recommended to improve cosmetic outcomes
or reduce scar width.
An updated Cochrane review [27] was carried out to de-
termine the effects of various tissue adhesives compared
with conventional skin closure techniques for the closure
of surgical wounds included 33 studies with a total of
2793 participants and demonstrated that there was low-
quality evidence that sutures were significantly better than
tissue adhesives for reducing the risk of wound breakdown
(dehiscence; RR 3.35; 95% CI 1.53 to 7.33; 10 trials, 736
participants that contributed data to the meta-analysis).
The number needed to treat for an additional harmful
outcome was calculated as 43. For all other outcomes—in-
fection, patient and operator satisfaction and cost—there
was no evidence of a difference for either sutures or tissue
adhesives. No evidence of differences was found between
tissue adhesives and tapes for minimizing dehiscence, in-
fection, patients’ assessment of cosmetic appearance, pa-
tient satisfaction, or surgeon satisfaction. The authors
concluded that sutures are significantly better than tissue
adhesives for minimizing dehiscence. In some cases, tissue
adhesives may be quicker to apply than sutures.
Coated sutures: are they useful?
Statement 2.: Triclosan-coated suture significantly reduces
SSI prevalence compared with the non-coated sutures (GoR
1B).
Sutures with antimicrobial properties were developed to
prevent microbial colonization of the suture material in
operative incisions. Early studies showed a reduction of
the number of bacteria in vitro and wound infections in
animals using triclosan-coated sutures, and this effect
was subsequently confirmed in clinical studies [28, 29].
Several novel antimicrobial coatings are now available,
but still, no clinical studies have been done that compare
the efficacy with non-coated sutures [30].
Wu et al. performed a systematic review to assess whether
the use of antimicrobial-coated sutures is more effective in
reducing the risk of SSI than the use of non-coated sutures.
Eighteen studies comparing triclosan-coated sutures vs
non-coated sutures (13 randomized controlled studies
and 5 observational studies) were included in the meta-
analysis for a total of 7458 patients; all studies investi-
gated triclosan-coated sutures and focused on adult pa-
tients, apart from one done in a pediatric population
[31]. The meta-analysis of the data demonstrated that
antimicrobial sutures significantly reduced SSI risk (for
RCTs: OR 0.72, 95% CI 0.59–0.88, P = 0.001, I2 = 14%;
for observational studies: OR 0.58, 95% CI 0.40–0.83,
P = 0.003, I2 = 22%). Only Vicryl Plus vs Vicryl revealed
consistent results in favor of antimicrobial sutures (for 7
De Simone et al. World Journal of Emergency Surgery           (2020) 15:10 Page 5 of 23
RCTs: OR 0.62, 95% CI 0.44–0.88, P = 0.007, I2 = 3%;
for 4 observational studies: OR 0.58, 95% CI 0.37–0.92,
P = 0.02, I2 = 41%). Besides, the effect of antimicrobial
coating was similar between different suture, wound
(clean, clean-contaminated, and mixed), and procedure
types (colorectal, cardio-vascular, head and neck, breast
surgical procedures). Quality of RCT evidence was
judged moderate, and observational studies’ evidence
was judged of very low quality and many studies had
conflicts of interest. The authors concluded that
triclosan-coated sutures may reduce SSI risk.
Uchino et al. [32] have recently analyzed the efficacy of
antimicrobial-coated sutures in preventing SSIs in digest-
ive surgery. A total of 5188 patients in 15 studies were in-
cluded, with 10 randomized controlled trials (RCT) and 5
observational studies (OBS). One study enrolled pediatric
patients. The sutured surgical sites in the included studies
were the abdominal fascia in 12 studies, the subcutaneous
alone in 1 study, and unknown in 2 studies.
Regarding the types of surgeries represented, there were
9 colorectal surgeries, 4 mixed digestive surgeries, 1 gas-
tric surgery, and 1 pancreaticoduodenectomy. The RCTs
included 6 studies that performed surgeries limited to
class 2 wounds or described the incidence distinct from
the wound class. Only one study was performed during
emergent surgeries and was limited to the dirty/infected
wound classes. The remaining 3 studies were analyses
conducted together with mixed wound classes. Regarding
the suture materials in the RCTs, monofilament sutures
were used in 4 RCTs, and poly-filament sutures were used
in 4 RCTs. Two RCTs used mixed suture materials. In
OBSs, nearly half of the participants had upper gastro-
intestinal surgery. The meta-analysis showed that in the
10 RCTs, the incidence rates of incisional SSIs were 160/
1798 (8.9%) with coated sutures and 205/1690 (12.1%)
with non-coated sutures. Overall, antimicrobial-coated su-
tures were superior for reducing the incidence of inci-
sional SSI (RR 0.67, 95% CI 0.48–0.94, P = 0.02) in RCTs
for digestive surgery with the mixed wound class and sur-
geries limited to a clean-contaminated wound (RR 0.66,
95% CI 0.44–0.98, P = 0.04). A superior effect of
antimicrobial-coated sutures was found in 9 RCTs that in-
volved only colorectal surgeries (RR 0.69, 95% CI 0.49–
0.98, P = 0.04). The superior effect of antimicrobial-coated
sutures was also found in OBSs (OR 0.4, 95% CI 0.3 to
0.54, P < 0.001). The mean hospital stay length was similar
to coated or uncoated sutures in 5 RCTs involving colo-
rectal surgery (mean difference (MD) − 5.00, 95% CI
16.68-6.69, P = 0.4) [32].
Guo et al. demonstrated that triclosan-coated sutures were
associated with a lower risk of SSI than uncoated sutures
across all surgeries (risk ratio [RR] 0.76, 95% confidence
interval [CI] 0.65–0.88, P < 0.001). Similar proportions of pa-
tients experienced wound dehiscence with either type of
suture (RR 0.97, 95% CI 0.49–1.89, P = 0.92). Subgroup ana-
lysis showed lower risk of SSI with triclosan-coated sutures
in abdominal surgeries (RR 0.70, 95% CI 0.50–0.99, P =
0.04) and group with prophylactic antibiotic (RR 0.79, 95%
CI 0.63–0.99, P = 0.04). However, such risk reduction was
not observed in cardiac surgeries, breast surgeries, or the
group without prophylactic antibiotics [33].
Henriksen et al. [34] in an overall comparison includ-
ing both triclosan-coated Vicryl and PDS sutures for
fascial closure, reported that triclosan-coated sutures
were superior in reducing the rate of SSI (OR 0.67; CI
0.46–0.98). The majority of the studies included only
elective surgery procedures. Four of these included only
colorectal procedures, whereas Diener et al. [35] in-
cluded all types of elective procedures through a midline
laparotomy. Justinger et al. [36] included both elective
and emergency laparotomies, whereas Ruiz-Tovar et al.
[37] included only cases with fecal peritonitis and Min-
gmalairak et al. [38] studied patients undergoing open
appendectomies. When evaluating PDS sutures separ-
ately, there was no effect of triclosan coating on the rate
of SSI (OR 0.85; CI 0.61–1.17). After trial sequential
analysis, authors concluded that triclosan-coated Vicryl
sutures for abdominal fascial closure significantly
decrease the risk of SSI and performing further RCTs
will not change this outcome, but there was no effect on
SSI rate with the use of triclosan-coated PDS sutures for
abdominal fascial closure [34]. That means that PDS
commonly used in abdominal surgery was not different.
Konstantelias et al. [39] analyzed 30 studies (19
randomized, 11 non-randomized; 15,385 procedures) giv-
ing evidence that triclosan-coated sutures were associated
with a lower risk of SSIs (risk ratio [RR] = 0.68; 95% confi-
dence interval [CI] 0.57–0.81). Triclosan-coated sutures
were associated with a lower risk for SSIs in high-quality
randomized studies (Jadad score 4 or 5). A lower risk for
the development of SSIs based on wound classification
was observed in clean, clean-contaminated, and contami-
nated but not for dirty procedures. No benefit was ob-
served in specific types of surgery: colorectal, cardiac,
lower limb vascular, or breast surgery.
A specific study on emergency surgery was also carried
out confirming these findings [40].
What is the role of intraoperative intraperitoneal
irrigation vs topic wound lavage with antibiotic solutions
to prevent surgical site infections?
Statement 3: There are insufficient data to support the role
of intraperitoneal or topic wound irrigation with antibiotics
in preventing SSI (GoR 2B).
Although intraoperative irrigation with antibiotic solu-
tions has been suggested to be beneficial in the preven-
tion of infections, no evidence-based results have been
made available. The effectiveness of intra-abdominal
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lavage with antibiotic solutions on the prevention of
postoperative SSI is controversial. Furthermore, issues
about its safety need to be examined as well as local ad-
verse effects (increased adhesion formation, postopera-
tive pain), selection of resistant bacteria, and tissue
toxicity.
The safety of the intraperitoneal administration of
antibacterial agents during or after surgery as prophy-
laxis or treatment of infection has been investigated in a
systematic review that included 29 RCTs and 50 obser-
vational studies [41].
The objective of this systematic review was to analyze
perioperative intraperitoneal administration of antibacter-
ial agents, to characterize the drugs used, and their safety
profile. Administration of topical intraperitoneal antibi-
otics both during and after surgery was studied. Amino-
glycosides, first- and second-generation cephalosporins,
tetracyclines, and penicillins were most commonly admin-
istered intraperitoneally during or after surgery. The anti-
bacterial agent was usually administered intraperitoneally
as monotherapy. However, some studies administered
combination regimens with heparin or with another anti-
bacterial agent. The most frequent combination was ami-
noglycosides and lincosamides. Only a few and mild
adverse events were reported and the authors concluded
that antibacterial agents can safely be administered intra-
peritoneally. However, they acknowledged that in 43% of
the included articles the adverse events were not reported
while 41% of the studies specified that there were no ad-
verse events related to the intraperitoneal administration
of drugs. The most frequently reported adverse event was
discomfort or pain during administration, especially with
the use of oxytetracycline [41].
Animal data about the relationship between intraperi-
toneal antibiotics and adhesion development are con-
flicting [42–46].
In the experimental study conducted by Sortini et al.
[43], the peritoneal lavage solution showing low adhesion
formation and high survival rates was saline solution at
37 °C. In this study, lavage with antiseptics was associated
with higher mortality (55–80% versus 0% for chlorhexi-
dine–iodine solutions and saline solution, respectively,
P < 0.001) but less adhesion formation (P < 0.001) as com-
pared to saline solution. The use of antibiotic solutions
was associated with 3% mortality in the treatment of peri-
tonitis but with higher Zühlke scores and adhesion forma-
tion as compared to saline solution (P < 0.001).
According to these data, antiseptic solutions should
not be recommended for peritoneal lavage.
Another experimental study was carried out to test
the effectiveness of the intraperitoneal application of
alternate antibiotics (Imipenem, ceftriaxone, and
cefazolin) in an abdominal sepsis model. These data
suggest that cephalosporins may be effective in
preventing adhesion formation in septic abdomens
compared to metronidazole [46].
Tetikcok et al. [47] have recently demonstrated that in
rats, peritoneal lavage with prednisolone improved sur-
vival rates with increasing doses in abdominal sepsis.
Abdominal lavage in rats was made using saline in group
1, equal volumes of cefazolin sodium in group 2, low-
dose methylprednisolone (1 mg/kg) in group 3, and
high-dose methylprednisolone (2 mg/kg) in group 4.
The study showed that the mortality rate of the rats in
group 2 was significantly higher than that in group 4,
which had no mortality (P = 0.032). Although insignifi-
cant, the lowest mean value of IL-1β, IL-2, and TNF-α
was in group 1, and the highest was in group 2. The low-
est IL-4 level was in group 3, and the highest level was
in group 2 (P = 0.41). Interleukin-10 levels were signifi-
cantly lower in group 4 and higher in group 2 (P =
0.014). The administration of prednisolone in this
abdominal sepsis model does not reflect a real-world
situation; however, the administration of prednisolone
alone helped to understand the effect of corticosteroids
without masking the effects with antibiotics.
A 2017 Cochrane review included 36 studies (6163
participants) comparing the use of antibacterial irriga-
tion with non-antibacterial irrigation [48]; authors re-
ported a lower incidence of SSI in patients treated with
antibacterial irrigation compared with non-antibacterial
irrigation (RR 0.57, 95% CI 0.44 to 0.75; I2 = 53%; 30
studies, 5141 participants). This was low-certainty evi-
dence downgraded once because 54% of the analysis
weight was contributed by studies at high risk of bias in
one or more domains, and once because publication bias
was considered likely to have affected the result. Besides,
the review pools together studies about intra-cavitary
and wound irrigation, antibiotics, and antiseptics as anti-
bacterial agents.
The possible benefit was present in each of the
surgical contamination subgroups (clean versus clean-
contaminated versus contaminated or dirty). The dif-
ference in adverse events, mortality, and abscess for-
mation did not reach statistical significance. The
hospital stay was reduced in the antibacterial irriga-
tion group.
Concerning intraoperative wound irrigation, Mueller
et al. in a meta-analysis of RCTs investigating the inci-
dence of postoperative SSI after intraoperative irrigation
of the surgical incision (after the closure of the fascia or
peritoneum and before skin closure) performed a sub-
group analysis comparing intraoperative wound irriga-
tion with topical antibiotics vs saline solution irrigation.
The study showed a significant reduction of postopera-
tive SSI when antibiotic solution irrigation was used
compared to both saline solution only irrigation and no
irrigation.
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The reported length of follow-up in the included trials
was 30 days or more in only 21 out of 41 trials. The
remaining trials reported follow-up times of as short as
5–10 days or did not specify the follow-up time at all.
Besides, the number and frequency of follow-up visits
varied largely, as did the type and blinding status of the
primary outcome assessor [49].
However, the considerable risk for bias of all the in-
cluded trials, their large heterogeneity, and the need to
balance those findings against the risk of impaired
wound healing and the potential increase of the bacterial
resistance suggest caution in the clinical application of
these results.
Could wound irrigation with saline and/or povidone
iodine solution be useful to prevent surgical site
infection?
Statement 4.: There are insufficient data to determine the
role of saline or povidone irrigation of incisional wounds
before closure to prevent SSI (GoR 2B)
Intraoperative wound irrigation refers to the flow of a solu-
tion across the surface of an open wound. It is a widely
practiced procedure and considered to help prevent SSI.
Among other benefits, wound irrigation is intended to
physically remove foreign material, cellular debris, sur-
face bacteria, and body fluids, to dilute possible contam-
ination and to function as a local antibacterial agent
when an antiseptic or antibiotic agent is used.
Wound irrigation must be vigorous enough to perform
the above goals but gentle enough to avoid further tissue
trauma or passage of bacteria and foreign material dee-
per into the wound. Practices vary depending on the pa-
tient population, the surface of the application, and the
solution used.
On the other hand, vigorous irrigation may remove pro-
tective immunologic cells that are enable healing to pro-
gress through a natural series of processes, including
inflammation and granulation, to final re-epithelialization
and remodeling. Exposed subcutaneous tissue provides a
favorable substratum for a wide variety of microorganisms
to contaminate and colonize, and if the involved tissue is
devitalized (e.g., ischemic, hypoxic, or necrotic) and the
host immune response is compromised, the conditions
become optimal for microbial growth [50]. A systematic
review was carried out to investigate whether intraopera-
tive wound irrigation (with or without active agents or
pressured application) affects the incidence of SSI. Studies
investigating the topical application of antibiotics or anti-
septics (e.g., powder, gels, sponges) were not included.
Twenty-one RCTs were identified comparing wound ir-
rigation with no wound irrigation in patients undergoing
various surgical procedures, and the results were substan-
tially heterogeneous [51]
Saline irrigation was not effective in reducing SSIs
[52]. However, when the saline was applied with a syr-
inge to generate some pressure [53], a reduction in the
risk of SSI compared with no irrigation was shown in
one study (OR 0.35; 95% CI 0.19–0.65; P = 0.0009). This
benefit also was demonstrated when pulse pressure irri-
gation with saline was compared with normal saline irri-
gation in a meta-analysis of two RCTs [54, 55] (OR 0.30;
95% CI 0.08–0.86; P = 0.0003).
In the same meta-analysis, a low quality of evidence
demonstrated a statistically significant benefit for inci-
sional wound irrigation with an aqueous povidone iodine
solution in clean and clean-contaminated wounds (OR
0.31; 95% CI 0.13–0.73; P = 0.007); 50 fewer SSI per
1000 procedures (from 19 fewer to 64 fewer) [51].
The 2017 Cochrane review comparing antibacterial ir-
rigation with non-antibacterial irrigation (36 studies,
6163 participants), the largest meta-analysis published,
reported a lower incidence of SSI in participants treated
with antibacterial irrigation compared with non-
antibacterial irrigation (RR 0.57, 95% CI 0.44 to 0.75;
I2 = 53%; 30 studies, 5141 participants) but evidence are
of low certainty [48].
Therefore, where a possible difference in the incidence
of SSI was identified (in comparisons of antibacterial
and non-antibacterial interventions, and pulsatile versus
standard methods), these should be considered in the
context of uncertainty, particularly given the possibility
of publication bias for the comparison of antibacterial
and non-antibacterial interventions.
Clinicians should also consider whether the evidence
is relevant to the surgical populations (wound classifica-
tion and setting) under consideration.
Are wound protector devices useful? (Table 3)
Statement 5.1: The use of wound protectors has protective
effects in reducing incisional SSI (GoR 1A);
Statement 5.2: The use of dual-ring constructed wound
protectors appears to be superior to single-ring devices in
preventing SSI (GoR 1B).
Wound protector devices (alternatively called “wound
guards” or “wound retractors”) have been increasingly used
in the effort to reduce SSI rates. These devices form a phys-
ical barrier between the wound edges and the contaminated
surgical field. More specifically, the impervious plastic bar-
rier prevents both endogenous and exogenous pathogens
from imbedding themselves within the wound (skin, fat,
fascia, peritoneum). This mechanism, in conjunction with
maintaining wound humidity and reducing direct physical
trauma from fixed retractors, is believed to reduce the risk
of incisional SSI. It must be noted however that some bac-
terial invasion could occur immediately before the insertion,
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or more likely after the removal of the wound protector it-
self. There are two widely available forms: a single ring that
lies within the abdominal cavity connected to a protective
drape that extends outward, or two rings that are connected
cylindrically by impenetrable plastic with one ring inside the
wound and the other secured on the outside [64].
The ROSSINI trial [56] is a multicenter observer-
blinded RCT carried up to determine the clinical effective-
ness of wound edge protection device (the device used
was the 3 M Steri-Drape Wound Edge Protector) in redu-
cing surgical site infection after abdominal surgery, enrol-
ling 760 patients with 382 patients assigned to the device
group and 378 to the control group, reported that a total
of 184 patients experienced surgical site infection within
30 days of surgery, 91/369 (24.7%) in the device group and
93/366 (25.4%) in the control group (odds ratio 0.97, 95%
confidence interval 0.69 to 1.36; P = 0.85). In the second-
ary analyses, no subgroup could be identified in which
there was evidence of clinical benefit associated with the
use of the device. The authors concluded that wound edge
protection devices cannot be recommended to reduce the
rate of SSI in patients undergoing laparotomy.
Gheorghe et al. cost-effectiveness analysis suggests
that the use of wound protector devices for SSI reduc-
tion cannot be justified and should be discontinued [64].
Previously, in 2012, Gheorghe et al. [57] reviewed 12
studies (2 prospective controlled studies +10 RCTs)
reporting primary data from 1933 patients. The quality
assessment found all of them to be at considerable risk
of bias. An exploratory meta-analysis was performed to
provide a quantitative indication of the wound edge pro-
tector device effect. The pooled risk ratio under a
random-effects model was 0.60 (95% confidence interval,
0.41–0.86), indicating a potentially significant benefit
from the use of the dispositive. No indications of signifi-
cant between-study heterogeneity or publication bias, re-
spectively, were identified.
In 2012, Edwards et al. [58] analyzed 6 RCTs for a
total of 1008 patients were included. They reported that
the use of a wound protector was associated with a
significant decrease in SSI (RR = 0.55, 95% CI 0.31–0.98,
P = 0.04). Data showed also a nonsignificant trend to-
ward greater protective effect in studies using a dual-
ring protector (RR = 0.31, 95% CI 0.14–0.67, P = 0.003),
rather than a single-ring protector (RR = 0.83, 95% CI
0.38–1.83, P = 0.64).
To assess these controversial results, several meta-analyses
have been published looking at the effectiveness of wound
protectors in preventing SSIs in abdominal surgeries.
In 2015, Mihaljevic et al. [59] analyzed 16 RCTs in-
cluding 3695 patients investigating wound edge protec-
tors published between 1972 and 2014. Data reported
that wound edge protectors significantly reduced the
rate of surgical site infections (risk ratio 0.65; 95%CI,
0.51–0.83; P = 0.0007; I2 2 = 52%). A similar effect size
was found in the subgroup of patients undergoing colo-
rectal surgery (risk ratio 0.65; 95%CI, 0.44–0.97; P =
0.04; I2 2 = 56%). Of the two common types of wound
Table 3 The effectiveness of wound protectors [57–63]: characteristics of the studies included in the review. RCT: randomized
controlled trial; SSI: surgical site infection; PCT: prospective controlled trial; GoR: grade of recommendation
Author and year of
publication
Type of study Number of
patients
Outcomes GoR
Pinkney TD et al.
2013 [56]
Multicenter RCT 760 Wound edge protection devices do not reduce the rate of surgical
site infection in patients undergoing laparotomy, and therefore
their routine use for this role cannot be recommended.
1A
Gheorghe A et al.
2012 [57]
Systematic review and meta-
analysis of 2 PCT + 10 RCT
1933 Wound edge protectors may be efficient in reducing SSI rates in
patients undergoing open abdominal surgery
1B
Edwards JP et al.
2012 [58]
Meta-analysis of 6 RCT 1008 Wound protectors reduce rates of SSI after gastrointestinal and biliary
surgery
1A
Mihaljevic AL et al.
2015 [59]
Systematic review and meta-
analysis of 16 RCT
3695 Wound edge protectors significantly reduce the rate of surgical site
infections in open abdominal surgery
1B
Zhang MX et al.
2015 [60]
Systematic review and meta-
analysis of 11 RCT
2344 Wound edge protector reduces the incidence of SSI in patients
receiving laparotomies, especially in the circumstance of dual-ring
type and in contaminated incisions. In order to fully assess the
effectiveness of WEP, large-scale and well-designed RCTs are still
needed in the future.
1B
Kang SI et al. 2018 [61] Systematic review and meta-
analysis of 14 RCT
2684 Potentially significant benefit from impervious plastic wound protector
use, greater protective effect in using dual-ring protector than a single
ring
1A
Sajid MS et al.
2017 [62]
Systematic review and meta-
analysis of 18 RCT
3808 Wound edge protector is associated with reduced incidence of overall
SSI in clean-contaminated and contaminated wounds
1B
Bressan AK et al.
2018 [63]
RCT 107 Among adult patients with intrabiliary stents, the use of a dual-ring
wound protector during pancreaticoduodenectomy significantly reduces
the risk of incisional SSI.
1A
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protectors, double-ring devices were found to exhibit a
greater protective effect (risk ratio 0.29; 95%CI, 0.15–
0.55) than single-ring devices (risk ratio 0.71; 95%CI,
0.54–0.92), but this might largely be due to the lower
quality of available data for double-ring devices. Explora-
tory subgroup analyses for the degree of contamination
showed a larger protective effect in contaminated cases
(0.44; 95%CI, 0.28–0.67; P = 0.0002, I2 2 = 23%) than in
clean-contaminated surgeries (0.72, 95%CI, 0.57–0.91;
P = 0.005; I2 2 = 46%) and a strong effect on the reduc-
tion of superficial surgical site infections (risk ratio 0.45;
95%CI, 0.24–0.82; P = 0.001; I2 2 = 72%) [59].
Zhang et al. reviewed 11 RCTs including 2344 pa-
tients. In particular, 6 trials (1589 patients) testing the
single-ring design wound edge protector did not show a
statistically significant reduction in SSI of laparotomy
(RR 0.76, 95% CI 0.51–1.12). Pooled analysis of the five
trials (755 patients) that tested the effect of dual-ring
wound protector on SSI showed a significant reduction
(RR 0.29, 95% CI 0.15–0.55). The combined data of the
11 trials favored the wound edge protector effect (RR
0.58, 95% CI 0.39–0.87). Analysis adjusted by the de-
grees of contamination revealed that wound protector
device is effective in reducing the incidence of SSI after
laparotomy incision contamination (RR 0.43, 0.26–0.72)
but failed to demonstrate such effect in clean/contami-
nated and dirty incisions (RR 0.72, 95% CI 0.43–1.21; RR
0.82, 95% CI 0.43–1.55, respectively) [60]
More specifically, two extremely recent systematic re-
views that evaluated 2684-patient and 3808-patient
RCTs respectively once again confirm this observation.
The first from Kang et al. [61] identified and analyzed
14 randomized controlled trials with a total of 2684 pa-
tients. The pooled risk ratio under a random-effects
model was 0.70 (95% confidence interval, 0.51-0.96; I2,
56.8%), indicating a potentially significant benefit from
impervious plastic wound protector use. There was a
significant trend toward greater protective effect in stud-
ies using a dual-ring protector (relative risk = 0.31; 95%
confidence interval, 0.15–0.58), rather than a single-ring
protector (relative risk = 0.84; 95% confidence interval,
0.71–1.00). There was no significant between-study het-
erogeneity or publication bias.
The second from Said et al. [62] analyzed 18 RCTs and
demonstrated that wound edge protector is associated
with the reduced incidence of overall SSI (OR 0.59; 95%
CI 0.43–0.81; z = 3.30; P < 0.001) and superficial SSI (OR
0.42; 95% CI 0.18–0.95; z = 2.09; P < 0.04). In addition, it
also successfully reduced the risk of SSI in clean-
contaminated wounds (OR 0.67; 95% CI 0.46–0.98; z =
2.06; P < 0.04) as well as in contaminated wounds (OR
0.24; 95% CI 0.12–0.49; z = 3.96; P < 0.0001). The reported
overall reduction in SSI was substantial in both reviews
(OR = 0.70 and 0.59 respectively).
When superficial (wound) SSI is the focus of the ana-
lysis, there is a further reduction in the postoperative rate
(OR = 0.42). Furthermore, these trends appear to extend
to both clean-contaminated and contaminated wounds
(OR = 0.67 and 0.24 respectively). While these compre-
hensive reviews and statistical analyses are compelling,
they omit a single large recent RCT that evaluated the role
of wound protectors in high-risk non-colorectal scenarios
(i.e., pancreaticoduodenectomies (PD) following preopera-
tive insertion of biliary stents for obstruction). This study
including a total of 107 patients reported a significant re-
duction in the incidence of incisional SSI in the wound
protector group (21.1% vs 44.0%; relative risk reduction
52%; P = 0.010). Patients with completed PD had a de-
crease in incisional SSI with the use of the wound pro-
tector compared with those undergoing palliative
operations (27.3% vs 48.7%; P = 0.04). Multivariate analysis
did not identify any significant modifying factor relation-
ships (estimated blood loss, duration of surgery, hospital
site, etc.) (P > 0.05) [63].
While the utility of wound protectors is clear, the su-
perior mechanical configuration of these devices remains
debated. More specifically, both single-ring (with or
without large adhesive drape components) and dual-ring
modalities (internal and external ring connected by im-
pervious plastic) are currently available. Two high-
quality analyses [61, 62] have both noted a strong trend
toward a greater protective effect with dual-ring variants
when compared to devices constructed with a single ex-
ternal ring and associated semi-adhesive drape. It is also
interesting to note that among this level 1 RCT data,
there is a clear modifying effect of the publication year.
In other words, as time has progressed in the study of
wound protectors (and therefore the evaluation of more
diverse surgical subgroups), their protective effect has
become increasingly evident.
In clinical practice, the only possible barrier to the
routine use of these types of devices is cost and availabil-
ity. A possible solution to decrease cost is to reserve
wound protectors for high-risk patients or dirty surgical
incisions to reduce SSI and equate costs related to
wound protectors and hospitalization(s).
Are adhesive sterile surgical incise drapes useful?
Statement 6.1: There is no evidence that plastic adhesive
drapes with or without antimicrobial properties are useful
to decrease SSI (GoR 2C).
Adhesive plastic incise drapes are used on a patient’s
skin after surgical site preparation, with or without anti-
microbial impregnation, and the surgeon performs the
incision of the drape and the skin simultaneously. There
are conflicting recommendations on the use of plastic
adhesive drapes, mainly discouraging their use.
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In 2015, the fourth update of the Cochrane review car-
ried out to investigate the advantages about using plastic
adhesive drapes to protect the wound from organisms
that may be present on the surrounding skin during sur-
gery, analyzed 5 studies with a total 3082 participants
comparing plastic adhesive drapes with no drapes and 2
studies involving 1113 participants comparing iodine-
impregnated adhesive drapes with no drapes. A signifi-
cantly higher proportion of patients in the adhesive
drape group developed a surgical site infection when
compared with no drapes (risk ratio (RR) 1.23, 95% con-
fidence interval (CI) 1.02 to 1.48, P = 0.03). Iodine-
impregnated adhesive drapes did not affect the surgical
site infection rate (RR 1.03, 95% CI 0.06 to 1.66,
P = 0.89). The length of hospital stay was similar in the
adhesive drape and non-adhesive drape groups. There
was no evidence from the 7 trials that plastic adhesive
drapes reduce surgical site infection rates and some evi-
dence that they increase infection rates [65].
In 2016, Allegranzi et al. analyzed 4 studies (one RCT,
one quasi-RCT, and two observational studies) compar-
ing adhesive iodine-impregnated incise drapes with no
drapes and showed no difference in the SSI risk (RCTs:
OR 2·62; 0·68–10·04; observational studies: OR 0·49;
0·16–1·49). Similarly, a meta-analysis of two RCTs com-
paring non-impregnated adhesive incise drapes to no
drapes showed no difference in the SSI risk (OR 1·10;
0·68–1·78) [66].
Recently, Rezapoor et al. carried out a prospective,
randomized clinical trial to evaluate the efficacy of
iodophor-impregnated adhesive drapes for reducing bac-
terial contamination and counts at the incision site dur-
ing hip surgery. The study enrolled 101 patients
undergoing open joint preservation procedure of the hip.
Half the patients had the adhesive drape applied to the
skin before incision, while the remainder underwent the
same surgery without a drape. Culture swabs were taken
from the surgical site at 5 points (pre skin preparation,
after skin preparation, post-incision, before subcutane-
ous closure, before dressing application) and sent for
culture and colony counts. After surgery, 12.0% of inci-
sions with adhesive drapes and 27.4% without adhesive
drapes were positive for bacterial colonization. It appears
that the iodophor-impregnated adhesive draping signifi-
cantly reduces bacterial colonization of the incision [67].
Recently, Zarei et al. have conducted a quasi-
experimental study with non-equivalent control group
design enrolling 88 patients who were the candidate for
lumbar spine surgery in the elective operating room to
investigate the effect of the incise drape on the rate of
bacterial contamination of surgical wound, and they
concluded that the use of ID is unable to reduce surgical
wound bacterial contamination in clean lumbar spine
surgery [68].
To drain or not to drain in closing surgical incision?
Statement 7.1: There are insufficient data to determine the
role of subcutaneous drainage of incisional wounds before
closure to prevent SSI in high-risk patients (GoR 2B).
Evidence regarding the utility of subcutaneous drains in
preventing incisional SSI are controversial.
The presence of fluid collection between the skin su-
tures and underlying fascia is thought to increase the
risk for SSIs, as it can provide a medium for bacterial
growth. The concept of subcutaneous drainage is to re-
move these fluids before they become infected, resulting
in a reduction of SSI.
Recently, several studies have examined suctioning/ac-
tive drainage systems as a means to prevent SSI in di-
gestive surgery, but the utility of these systems is still
controversial [69, 70].
Fuji et al. assessed the efficiency of subcutaneous
drains for high-risk patients undergoing colorectal
surgery, including patients with thick subcutaneous fat
tissue and those undergoing emergency operations. They
enrolled in their 79 high-risk patients for SSI. The over-
all incidence of incisional SSI was 27.8%. The incidences
of incisional SSI in these cases with or without a sub-
cutaneous drain were 14.3% and 38.6%, respectively. The
authors concluded that subcutaneous drains are effective
for preventing incisional SSI in patients with thick sub-
cutaneous fat in colorectal surgery [71].
In 2013, Kosins et al. [72] reviewed and analyzed 52
randomized controlled trials with a total of 6930 opera-
tions aimed to determine the evidenced-based value of
prophylactic drainage of subcutaneous wounds in sur-
gery. Subgroups were determined by specific surgical
procedures or characteristics (cesarean delivery, abdom-
inal wound, breast reduction, breast biopsy, femoral
wound, axillary lymph node dissection, hip and knee
arthroplasty, obesity, and clean-contaminated wound).
There were 3495 operations in the drain group and 3435
in the no-drain group. Prophylactic subcutaneous drain-
age offered a statistically significant advantage only for
the prevention of hematomas in breast biopsy proce-
dures and the prevention of seromas in axillary node dis-
sections. In all other procedures studied, drainage did
not offer an advantage.
The authors concluded that drain placement following
a surgical procedure is the surgeon’s choice and can be
based on multiple factors beyond the type of procedure
being performed or the patient’s body habitus [72].
All the previous studies assessed the usefulness of
active-suctioning subcutaneous drain in a closed surgical
wound. Numata et al. [73] decided to evaluate the efficacy
of a passive drainage system for preventing surgical site in-
fections during major colorectal surgery, enrolling 246
(124 underwent passive drainage, and 122 underwent no
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drainage) patients who underwent major colorectal sur-
gery. Patients were randomly assigned to receive subcuta-
neous passive drainage or no drainage. The primary
outcome measured was the incidence of superficial SSI.
The secondary outcomes measured were the development
of hematomas, seromas, and wound dehiscence.
They reported a significant difference in the incidence
of superficial SSIs between patients assigned to the
passive drainage and no drainage groups (3.2% vs 9.8%,
respectively, P = 0.041). There were no cases that devel-
oped a hematoma, seroma, or wound dehiscence in ei-
ther group. The authors concluded that subcutaneous
passive drainage provides benefits over no drainage in
patients undergoing major colorectal surgery.
The benefit of subcutaneous drainage was studied also
in ileostomy closure that is in a dirty surgical field; after
having conducted an RCT, Lauscher et al. [74] were able
to affirm that the omission of subcutaneous suction
drains is not inferior to the use of subcutaneous suction
drains after ileostomy reversal in terms of length of
hospital stay, surgical site infections, and hematomas/
seromas.
In another RCT, the rate of SSI appeared to be re-
duced with subcutaneous suction drains in open abdom-
inal surgery, but the authors concluded that prospective
randomized larger-scale studies should be performed to
confirm data [75].
Recently, Watanabe et al. [76] decided to evaluate the
effects of subcutaneous closed-suction Blake drain for
preventing SSIs after colorectal surgery performing an
RCT, enrolling 240 patients. The incidence of incisional
SSI was 8.7% in the overall patients. The incidence of in-
cisional SSI was 12.8% in the control arm and 4.5% in
the subcutaneous drainage arm. They reported a signifi-
cant reduction of the incidence of SSI in the subcutane-
ous drainage arm than in the control arm (P = 0.025).
Logistic regression analysis demonstrated that thickness
of subcutaneous fat > 3.0 cm, forced expiratory volume
in 1 s as percent of forced vital capacity (FEV1.0%) >
70%, and subcutaneous drain were independent predic-
tors of postoperative incisional SSIs (P = 0.008, P =
0.004, and P = 0.017, respectively). The authors af-
firmed that a subcutaneous Blake drain is beneficial for
preventing incisional SSIs in patients undergoing colo-
rectal surgery [76].
Manzoor et al. [77] after reviewing the literature to as-
sess the evidence on the efficacy of subcutaneous wound
drainage in reducing SSI concluded that not all patients
will benefit from subcutaneous drainage. Subcutaneous
wound drainage seems to be useful in patients with high
risk to develop an SSI including patients who are obese
and/or have contaminated wounds but in clean and
clean-contaminated surgical wounds, it remains a sur-
geon’s choice [77].
When is double gloving recommended? When is
changing gloves recommended during an operation?
Statement 8.1: There are insufficient data to determine the
role of double gloving to prevent SSI (GoR 2B).
Statement 8.2: The mechanical resistance of latex gloves
depends on the duration of wear. It may be beneficial for
surgical team members and their protection to change
gloves at certain intervals during surgery [GoR 2C].
Surgical gloves are an important physical barrier be-
tween the surgical staff and the patient. They enable the
prevention of transmission of microorganisms in both
directions, from the surgeons’ hands to the patient.
The integrity of gloves depends on the duration of
wearing, the role within the surgical team, and the type
of surgery performed.
Their use since the beginning was a barrier against in-
fections. With the recognition of HIV infection and the
associated concerns about transmission of HBV and
hepatitis C virus in the operating room during the 1980s
and early 1990s, considerable interest emerged in the
provision of better protection of the hands for surgical
personnel [78].
The intact surgical glove is the most important bar-
rier to the bi-directional migration of microorganisms
between the hands of the members of a surgical team
and the patient. Several studies have shown that un-
detected perforations of surgical gloves are common
and that the frequency of such defects increases with
the duration of glove wear. The risk of glove defects
is related to the type of surgery being done, ranging
from 7% in urologic surgery to 65% in cardiothoracic
surgery [78, 79].
Various measures have been developed to reduce the
risk of surgical site contamination with microorganisms
originating from the surgeon’s hands.
Standard practice for decreasing the microbial bio-
burden on the hands of surgeons and other surgical
team members is preoperative surgical hand disinfection
with an antimicrobial soap (surgical scrub) or an
alcohol-based hand disinfectant (surgical rub). Preopera-
tive surgical hand disinfection can reduce, but not eradi-
cate, the resident flora on the surgeon’s hands. Because
of the re-growth of skin flora during a surgical proced-
ure, original levels of skin flora on a surgeon’s hands can
be re-established within 3–6 h, depending on the formu-
lation of the product used to disinfect the hands [78].
A novel sterile antimicrobial surgical glove, featuring a
proprietary complex coating with 14 ingredients and
chlorhexidine as an active antimicrobial ingredient on its
inner surface, has been developed to reduce the risk of
contamination of the surgical site in the event of a glove
breach. Further clinical studies are needed to confirm
this concept [79].
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Double gloving has been demonstrated to reduce
blood contact with the hands of the operating team.
Quebbeman and colleagues noted a nearly 90% reduc-
tion in hand exposure to blood with double gloving
in a prospective, randomized trial [80]. Wearing two
pairs of latex gloves significantly reduces the number
of perforations to the innermost glove. This evidence
comes from trials undertaken in “low-risk” surgical
specialties. Wearing two pairs of latex gloves does not
cause the glove wearer to sustain more perforations
to their outermost glove. Wearing double latex indi-
cator gloves enables the glove wearer to detect perfo-
rations to the outermost glove more easily than when
wearing double latex gloves. However wearing a
double latex indicator system will not assist with the
detection of perforations to the innermost glove, nor
reduce the number of perforations to either the
outermost or the innermost glove. There is no direct
evidence that additional glove protection worn by the
surgical team reduces surgical site infections in pa-
tients; however, the most important published review
has insufficient power for this outcome [81]..
The adequate protection, however, requires that the
glove material remain intact. The electrical conductivity,
insulation, and mechanical resistance of glove latex de-
pend on the duration of wear. Latex is subject to hydra-
tion; 30 min of surgical use was associated with
measurable hydration of glove latex and a statistically
significant loss of electrical and mechanical resistance,
with rupture load decreasing by 24% [82].
Parteke et al. prospectively collected 898 consecutive
pairs of used surgical gloves over 9 months in a single in-
stitution and reported that wearing gloves for 90 min or
less resulted in microperforations in 46 (15.4%) of 299
pairs of gloves, whereas wearing gloves for 91–150 min re-
sulted in perforation of 54 (18.1%) of 299 pairs, and 71 of
(23.7%) of 300 pairs were perforated when the duration of
wear was longer than 150 min (P = .05). Because of the in-
crease in the rate of microperforation over time, authors
recommended that surgeons, first assistants, and surgical
nurses directly assisting in the operating field change
gloves after 90 min of surgery [83].
Several studies demonstrated that the occurrence of
microperforations in surgical gloves increases over
time.
Even in orthopedic surgery, surgical gloves should be
changed when they are excessively contaminated with
surgical fluids and the surgeon and first assistant should
also change their outer gloves at an average of every
90 min [84].
Glove perforation rates are high in open abdominal sur-
gery; considering data available, it may be beneficial for
surgical team members to change gloves at certain inter-
vals during surgery or use indicator glove systems [84].
Is negative-pressure wound dressing useful to prevent
surgical site infections? (Table 4)
Statement 9: The application of negative-pressure wound
therapy in preventing SSI may be effective in reducing
postoperative wound complications and it may be an option,
especially in patients with a high risk of SSI. (GoR 2C).
Gomoll et al. [93] first reported the application of
negative-pressure wound therapy in closed incisions
(cINPT), and their outcomes showed that its use for
treating closed incisions in orthopedic surgery can re-
duce the incidence of SSI.
A subsequent series of reports [85–87] confirmed the
effectiveness of cINPT in reducing SSI.
In 2015, Sandy-Hodgetts et al. [88] decided to conduct a
systematic review and meta-analysis of all papers available
from 1990 to 2013 evaluating the effectiveness of cINPT
in preventing postoperative surgical wound complications.
Eight studies were included in the review. Meta-analyses
revealed a statistically significant difference in favor of the
use of cINPT as compared with standard surgical dress-
ings in managing SSI, but conflicting results were found
for wound dehiscence and seroma. Considering the small
number of studies included and that most of them were
retrospective comparative cohort in design, authors could
not recommend cINPT to prevent SSI even if the study
demonstrated an association between the use of cINPT
and reduction of SSI.
A more recent meta-analysis by Strugala et al. [89]
investigated the effectiveness of prophylactic use of a
specific design of cINPT device on surgical site compli-
cations. The authors considered all articles comparing
the specific single-use cINPT device (PICO) with stand-
ard care for SSI in closed surgical wounds. Ten random-
ized and 6 observational studies were selected with a
total of 1863 patients (2202 incisions) included. The ran-
domized studies reported a significant reduction in SSI
rate of 51% from 9.7 to 4.8% with cINPT intervention
(RR 0.49 [95% CI 0.34–0.69] P < 0.0001). The observa-
tional studies assessed a reduction in SSI rate of 67%
from 22.5 to 7.4% with cINPT (RR 0.32 [95% CI 0.18–
0.55] P < 0.0001). Pooling all the data, there was a sig-
nificant reduction in SSI of 58% from 12.5 to 5.2% with
cINPT (RR 0.43 [95% CI 0.32–0.57] P < 0.0001) regard-
less of the type of surgery (orthopedic, abdominal, colo-
rectal, or cesarean section), although the numbers
needed to treat were lower in operations with higher fre-
quencies of complications. Furthermore, meta-analysis
showed a significant reduction in dehiscence from 17.4
to 12.8% with cINPT (RR 0.71 [95% CI 0.54–0.92]
P < 0.01) and in-hospital length of stay by cINPT (− 0.47
days [95% CI − 0.71 to − 0.23] P < 0.0001).
Another meta-analysis carried out by Sahebally et al.
[90] in 2018 evaluated the association of prophylactic
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cINPT with SSI rates in general and colorectal surgery
in elective and emergency settings.
Three randomized trials and 2 prospective and 4 retro-
spective studies were selected for the meta-analysis, in-
volving 1187 patients with 1189 incisions. The authors
found significant clinical and methodologic heterogeneity
among the studies. On random-effects analysis, cINPT
was associated with a significantly lower rate of SSI com-
pared with standard dressings (pooled odds ratio [OR],
0.25; 95% CI, 0.12–0.52; P < .001) but no difference in
rates of seroma (pooled OR, 0.38; 95% CI, 0.12–1.23;
P = .11) or wound dehiscence (pooled OR, 2.03; 95% CI,
0.61–6.78; P = 0.25). On sensitivity analysis, focusing
solely on colorectal procedures, cINPT significantly re-
duced SSI rates (pooled OR, 0.16; 95% CI, 0.07–0.36;
P < .001). Thus, this study demonstrated that the applica-
tion of cINPT on closed laparotomy wounds in general
and in colorectal surgery is associated with reduced SSI
rates but no different significant rates of seroma and
wound dehiscence compared with traditional dressings.
Readership expressed some criticisms about the clin-
ical value of these outcomes considering the high level
of statistical heterogeneity associated with the included
studies in the discussion and the necessity for random-
ized controlled trials before recommending the applica-
tion of cINPT in clinical practice.
Uncertainty in the indications for the use of cINPT had
been reported in 2012 [91] and then confirmed in 2014
[92] and the updated 2019 [94] version of the Cochrane
systematic review. In the last systematic review, despite
the addition of 25 trials, the authors judged the evidence
to be low or very low certainty for all outcomes.
The study involved 2957 participants (30 intervention
trials and two economic studies nested in trials). Surger-
ies included abdominal and colorectal (n = 5); cesarean
sections (n = 5); knee or hip arthroplasties (n = 5); groin
Table 4 Negative wound dressing in preventing SSI: characteristics of the studies included in the review [85–96]. SSI surgical site
infection, RCT randomized controlled trial, GoR grade of recommendation, NPWT negative-pressure wound therapy, LOS lengh of
hospital stay
Author and year of
publication
Type of study Number of
patients
Outcomes GoR
Sandy-Hodgetts K
et al. (2015) [88]
Systematic review and meta-analysis of 8
(RCT, pseudo-randomized trials,
quasi-experimental studies, prospective
and retrospective cohort studies, case
control studies, and analytical cross
sectional studies)
1277 NPWT in preference to standard postoperative
dressings may be considered for closed surgical
incisions in adults assessed as high-risk for SSI;
further research is needed (level 1 studies—RCT)
on patients identified as “at risk” in the
preoperative period.
2C
Strugala V et al.
2017 [89]
Meta-analysis of 10 RCT + 6 prospective
observational trials
1863 The significant reduction in SSI, wound dehiscence,
and LOS on the basis of pooled data shows a
benefit of the PICO single-use NPWT system
compared with standard care in closed surgical incisions.
1A
Sahebally SM et al.
2018 [90]
Systematic review and meta-analysis of
9 studies (3 RCT and 2 prospective and
4 retrospective studies)
1266 Application of NPWT on closed laparotomy wounds
in general and colorectal surgery is associated with
reduced SSI rates but similar rates of seroma and
wound dehiscence compared with conventional
nonpressure dressings.
2C
Webster J et al. 2019 [94] Cochrain systematic review
(30 interventional studies)
2957 uncertainty remains about whether NPWT compared
with a standard dressing reduces or increases the
incidence of important outcomes such as mortality,
dehiscence, seroma, or if it increases costs. Given the
cost and widespread use of NPWT for SSI prophylaxis,
there is an urgent need for larger, well-designed and
well-conducted trials to evaluate the effects of newer
NPWT products designed for use on clean, closed
surgical incisions. Such trials should initially focus on
wounds that may be difficult to heal, such as sternal
wounds or incisions on obese patients.
2C
Katsuki Danno et al.
2018 [95]
Prospective study 28 The use of NPWT is an effective measure for preventing
SSI in patients undergoing abdominal surgery for peritonitis
caused by lower-gastrointestinal perforation.
2C
Lozano-Balderas G
et al. 2017 [96]
Prospective randomized study 81 Statistical significance was found between infection rates
of the vacuum-assisted group and the other two groups
(primary closure and delayed primary closure). The infection
rate in contaminated/dirty-infected laparotomy wounds
decreases from 37 and 17% with primary and delayed
primary closures, respectively, to 0% with vacuum-assisted
systems.
1C
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surgery (n = 5); fractures (n = 5); laparotomy (n = 1);
vascular surgery (n = 1); sternotomy (n = 1); breast re-
duction mammoplasty (n = 1); and mixed (n = 1). Web-
ster et al. showed uncertainty about whether cINPT
compared with a standard dressing reduces or increases
the incidence of important outcomes such as mortality,
dehiscence, and seroma or if it increases costs. Given the
cost and widespread use of cINPT for SSI prophylaxis,
authors claimed an urgent need for larger, well-designed
and well-conducted trials to evaluate the effects of newer
cINPT products designed for use on clean, closed surgi-
cal incisions.
Several studies investigated the role of cINPT in con-
taminated and dirty surgical wounds.
Danno et al. [95] prospectively included in their study
28 patients undergoing abdominal surgery for peritonitis
caused by a lower-gastrointestinal perforation. They com-
pared data from this group with a 19 patients historical
control group who had undergone primary suturing for
managing peritonitis incisions for a lower-gastrointestinal
perforation. Authors reported a significant association be-
tween the SSI incidence and the type of incision manage-
ment (10.7% with cINPT and delayed closure vs. 63.2%
with primary suturing; P < 0.001); no significant difference
between the groups in the length of the hospital stay (22
days for cINPT and delayed closure vs. 27 days for pri-
mary suturing; P = 0.45) was found.
Therefore, the association of cINPT and delayed closure
of the abdominal wall is an effective method to prevent SSI.
A Spanish group [96] decided to compare outcomes
about three techniques used for wound management
after laparotomy in contaminated and dirty/infected
wounds: the primary, delayed primary, and vacuum-
assisted closures in terms of SSI. Eighty-one patients
undergone laparotomy with Class III or IV surgical
wounds were enrolled in a three-arm randomized pro-
spective study. Twenty-seven patients received primary
closure, 29 delayed primary closure, and 25 vacuum-
assisted closure, with no exclusions for analysis. Surgical
site infection was present in 10 (37%) patients treated
with primary closure, 5 (17%) with primary delayed
closure, and 0 (0%) patients receiving vacuum-assisted
closure. Statistical significance was found between infec-
tion rates of the vacuum-assisted group and the other
two groups. No significant difference was found between
the primary and primary delayed closure groups. The in-
fection rate in contaminated/dirty-infected laparotomy
wounds decreases from 37 and 17% with primary and de-
layed closures, respectively, to 0% with vacuum-assisted
systems [96]. We have to consider that in this study the
number of patients is very small for each group.
Several studies evaluated the cost-utility of cINPT in
preventing SSIs compared to standard dressings and
demonstrated that the use of closed-incision negative-
pressure therapy is cost-saving following the closure of
abdominal incisions in high-risk patients [97–99].
Furthermore, to obviate the high costs related to
current equipment for cINPT, more cost-effective alter-
natives were developed using standard gauze sealed with
an occlusive dressing and wall suction. Several studies
comparing both methods of treatment appear to be
similarly effective for reducing wound surface area and
volume [94, 100, 101].
Is intraoperative normothermia useful to prevent surgical
site infections?
Statement 10.1: Intraoperative normothermia decreases the
rate of SSI (GoR 1A).
Statement 10.2: The use of active warming devices in
operating room is useful to keep normothermia and reduce
SSI (GoR 1B).
Core body temperature is kept in a narrow range by sev-
eral mechanisms, namely heat genesis and thermal
insulation (mainly vasoconstriction or dilatation). This
balance is greatly challenged during major surgery. On
the one hand, surgery may imply exposure of large sur-
face areas with consequent loss of heat and fluids. On
the other hand, anesthesia disrupts the temperature
setpoint (i.e., a lower than usual temperature triggers an
adaptive reflex as shivering or metabolic thermogenesis)
and can increase heat loss by vasodilatation [102]. Animal
studies have shown that hypothermia increases complica-
tions such as infection, myocardial infarction, and
coagulation derangements. Perioperative hypothermia can
increase SSI due to its reflex vasoconstriction and medi-
ated local immunosuppression. Vasoconstriction reduces
partial oxygen pressure which lowers resistance to infec-
tions in animal models [103].
Perioperative normothermia has been addressed by
several studies, papers, and meta-analysis. Considering
only RCTs, the subsequent comparisons, but not limited
to them, have been evaluated: head-to-head RCTs of one
active warming device vs another, different extension of
the active warming period through the perioperative
one, active warming device vs no warming, warming of
fluids and or insufflation gases during laparoscopic vs no
active warming. We decided to focus on RCTs compar-
ing interventions aimed at preventing hypothermia vs a
control group where no such an intervention was imple-
mented (a placebo group), the outcome was the inci-
dence of SSI. Four relevant papers were analyzed [104,
105]. All of them dealt with an active body warming de-
vice against the placebo.
Kurz et al. [105] in 1996 randomized 200 patients sched-
uled for major abdominal contaminated surgery to receive
active body surface warming by a forced-air warmer device.
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The incidence of SSI was 6/104 in the intervention group
and 18/96 in the control one (P = 0.009).
Melling et al. [106] in 2001 randomized 421 patients
scheduled for clean surgery into three arms placebo,
local warming (non-contact, radiant heat dressing), and
systemic warming (forced-air warming device). Pooling
the data of the two intervention groups, the incidence of
SSI was 19/139 in the placebo group vs 13/277 in the
intervention group (P = 0.001).
Pu et al. [107] in 2014 randomized 110 patients sched-
uled for laparoscopic gastrointestinal procedure into
placebo group vs systemic warming (disposable under-
body warming blanket with reusable forced-air warming
system). The incidence of SSI was 0 in both the inter-
vention and control groups.
Yi et al. [104] in 2018 randomized, in an open-label,
pilot study 62 patients scheduled for open thoracic or
hip replacement surgery to systemic warming (forced-air
warming device) vs control (quilt). The incidence of SSI
was 0/32 in the control group and 3/30 in the warming
group (P = 0.238).
The effectiveness of temperature measurement in
preventing SSIs has been assessed in a large cohort 2013
study in the colonic surgery population [108]. Several
meta-analyses have been published on the topic. A re-
cent Cochrane review from Madrid et al. [106] reviewed
the literature and found a significant decrease in SSI
after the implementation of an active warming interven-
tion (risk ratio (RR) 0.36, 95% confidence interval (CI)
0.20 to 0.66; P = 0.0008; I2 = 0%); the studies were rated
of fair quality. Another meta-analysis reached the same
conclusions [106]. There exists little debate around the
effectiveness of reducing SSI by keeping the patients
normothermic throughout the perioperative period. Four
RCTs [100–103] and at least two meta-analyses [109,
110] confirm this risk reduction. It seems unlikely that
other RCTs comparing a device to keep normothermia
will be compared with a placebo group as this recom-
mendation has been implemented in several national
and international guidelines [111–114]. The last two
RCTs [104, 107] with a real placebo group have been
carried out in a nation where it is not common practice
to warm patients during surgery. Those studies [100,
103] were meant to be pilot studies to assess the feasibil-
ity of forced-air warming in that context.
The two open questions are which device and/or strat-
egy should be used and when (only intraoperative or
intraoperative and pre- and/or postoperative?). There
are three main devices to warm up the patients: forced-
air warming (so far the most studied and used world-
wide), resistive polymer fabric warming, and circulatory
warming systems using a closed fluid circuit. The use of
radiant heating systems is considered feasible only dur-
ing pediatric procedures. On the other side, other
strategies have been implemented to reduce heat loss
and prevent hypothermia (e.g., warm iv infusion, warm
irrigation fluids or gases for pneumoperitoneum during
laparoscopic, preoperative infusion of nutrients to in-
crease metabolic rate and protein turn-over, reflective
blankets). A thorough evaluation of those questions is
outside the statement. The majority of those studies has
as main outcome the achievement of normothermia and
were not powered enough to detect a difference in SSI.
To date, Madrid et al. [109] evaluated in their meta-
analysis the studies comparing head-to-head the differ-
ent modality to warm up the patients and found no
differences in SSI incidence. The main concern is the
use of forced-air warming devices in surgery where
air-borne pathogens are a major threat to orthopedic
prosthesis surgery. In this particular scenario, the sur-
gery takes place under the condition of ultra clean
ventilation, at least in affluent countries, and it is
known that forced-air disrupt the laminar flow and
increases a load of bacteria at the operation site (in
lab models). The bacterial load is the main risk factor
for prosthesis colonization [115]. A systematic review
is available but results are inconclusive [116]. Anyway,
this hypothesis has not been formally tested in an ad-
equately powered RCT.
The timing of warming has been evaluated in several pa-
pers. Pre-emptive warming plus intraoperative warming
has shown better results in providing normothermia than
intraoperative warming alone in small RCTs [117–119]
and in a systematic meta-analysis [120]. Heterogeneity be-
tween the studies is high as well as the results from the
single trials and the meta-analysis was not conclusive.
Several guidelines from national and international in-
stitutions stated in favor of achieving normothermia in
the perioperative period to reduce the incidence of SSI
[111–114].
Is perioperative supplemental oxygen effective to reduce
SSI?
Statement 11: Perioperative hyperoxygenation does not
reduce SSI (GoR 2B).
The most important defense against SSI is oxidative
killing by neutrophils, and molecular oxygen is the
substrate of the process. The easiest way to increase
tissue oxygenation is to increase inspired oxygen. For
example, intraoperative tissue oxygen partial pressure
is typically about 6.6 kPa in patients given 30% in-
spired oxygen and about13.3 kPa in those given 80%
inspired oxygen [121].
Despite some early evidence [121], there have since
been conflicting results from numerous randomized
clinical trials.
Two well-conducted randomized trials (n = 500 and
n = 300) [121, 122], a smaller trial [123] and a registry
De Simone et al. World Journal of Emergency Surgery           (2020) 15:10 Page 16 of 23
analysis [124], suggested that supplemental oxygen (80%
vs 30%) halved infection risk, supporting the role of sup-
plemental oxygen in reducing the risk of SSI. However,
other studies have not been able to confirm this.
The PROXI trial [125], that is a large, multicenter,
randomized trial involving 1400 patients undergoing
abdominal surgery, found no evidence of any beneficial
effect of supplemental oxygen; in fact, SSI occurred in
131 of 685 patients (19%) receiving 80% oxygen and in
141 of 701 (20%) receiving 30% oxygen [odds ratio 0.94
(95% confidence interval 0.72–1.22), P = 0.64]. Indeed, a
long-term follow-up study (median 2.3 years after sur-
gery) found poorer survival in the supplemental oxygen
group [126].
Another recently published randomized, blinded
trial including 400 patients [127] tested the hypothesis
that extending intraoperative supplemental oxygen 12
to 16 h into the postoperative period reduces the risk
of SSI and healing-related complications in the mor-
bidly obese patients and reported no benefit of sup-
plemental oxygen.
In 2018, Cohen et al. [128] published a meta-
analysis including 26 trials with a total of 14,710 pa-
tients, to investigate the effect. The RR [95%CI] for
wound infection was 0.81 [0.70, 0.94] in the high vs.
low inspired oxygen groups. The effect remained sig-
nificant in colorectal patients (10,469 patients), 0.79
[0.66, 0.96], but not in other patients (4,241 patients),
0.86 [0.69, 1.09]. When restricting the analysis to
studies with low risk of bias, either by strict inclusion
criteria (5047 patients) or by researchers’ judgment
(12,547 patients), no significant benefit remained: 0.84
[0.67, 1.06] and 0.89 [0.76, 1.05], respectively. The au-
thors concluded that meta-analysis of the most reli-
able studies does not suggest that supplemental
oxygen substantively reduces wound infection risk
when considering all available data, but more research
is needed to fully answer this question.
Whether supplemental oxygen, which is inexpensive
and easy to provide, reduces infection risk, thus remains
in dispute.
Leaving the skin open for delayed primary closure can
reduce SSI?
Statement 12.1: Delayed primary skin closure may reduce
the incidence of SSI (GoR2C).
Statement 12.2: Delayed primary closure of a surgical
incision is an option to take into consideration in
contaminated abdominal surgeries in high-risk patients
(GoR 2C).
Delayed primary closure of dirty wounds has been
widely practiced in war surgery; it is a procedure which
aims to reduce the rate of SSI by suturing a wound later
after proper dressing, considering the fundamental prin-
ciples of decreasing bacterial inoculums and potentiating
local wound resistance from increasing wound oxygen-
ation and blood supply from developing granulation tis-
sue. It was first applied to traumatic wounds and later
was more widely applied to various types of operations
with the demonstration of good efficacy [129–131].
These results were mainly from observational studies
that may be prone to selection and confounding biases.
Besides, the delayed primary closure also has its disad-
vantages including pain from routine dressing, the ne-
cessity for later wound suturing, and increase the cost of
treatments [129–132].
In 2013, Bhangu et al. [132] decided to determine using
meta-analysis whether delayed primary skin closure of
contaminated and dirty abdominal incisions reduces the
rate of SSI compared with primary skin closure.
The authors included in the final analysis 8 studies
randomizing 623 patients with contaminated or dirty ab-
dominal wounds to either delayed primary skin closure
or primary closure. The most common diagnosis was ap-
pendicitis (77.4%), followed by perforated abdominal
viscus (11.5%), ileostomy closure (6.5%), trauma (2.7%),
and intra-abdominal abscess/other peritonitis (1.9%).
The time to the first review for delayed primary skin
closure was provided at between 2 and 5 days postopera-
tively. All studies were found to be at high risk of bias,
with marked deficiencies in study design and outcome
assessment. When SSI was assessed across all studies
using a fixed-effect model, delayed primary skin closure
significantly reduced the chance of SSI (odds ratio, 0.65;
95% CI, 0.40–0.93; P = .02). However, heterogeneity was
high (72%), and using a random-effects model, the effect
was no longer significant (odds ratio, 0.65; 95% CI, 0.25–
1.64; P = .36).
The authors concluded that delayed primary skin clos-
ure may reduce the rate of SSI, but current trials fail to
provide definitive evidence.
In 2014, Siribumrungwong et al. [133] decided to
investigate the same topic carrying out a systematic
review and meta-analysis to compare SSI between de-
layed primary and primary wound closure in compli-
cated appendicitis and other contaminated abdominal
wounds. Eight studies were considered for meta-
analysis: 5 studies were done in complicated appendi-
citis, 2 with mixed complicated appendicitis and other
types of abdominal operation, and 1 with ileostomy
closure. Most studies (75%) had a high risk of bias in
sequence generation and allocation concealment.
Among 6 RCTs of complicated appendicitis that
underwent open appendectomy, the SSI between pri-
mary closure and delayed primary closure were not
significantly different with a risk ratio of 0.89 (95% CI,
0.46, 1.73). Delayed primary closure had significantly
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1.6 days (95% CI: 1.41, 1.79) longer length of stay than
primary closure.
Based on a small number of studies with low-quality, a
meta-analysis suggested there might be no advantage of
delayed primary closure over primary closure in redu-
cing SSI in complicated appendicitis.
After this meta-analysis, Siribumrungwong et al. [134]
carried out a multicenter randomized controlled trial to
compare superficial SSI rates between delayed primary
wound closure and primary wound closure for compli-
cated appendicitis.
The study enrolled and randomized 300 and 298
patients with gangrenous and ruptured appendicitis to
primary closure and delayed primary closure (at postop-
erative days 3–5) groups.
The superficial SSI rate was lower in the primary
closure than in delayed primary closure groups [i.e.,
7.3% (95% confidence interval 4.4, 10.3) vs 10% (95% CI
6.6, 13.3)] with a risk difference (RD) of − 2.7% (− 7.1%,
1.9%), but this RD was not significant. Postoperative
pain, length of stay, recovery times, and quality of life
were nonsignificantly different with corresponding RDs
of 0.3 (− 2.5, 3.0), − 0.1 (− 0.5, 0.3), − 0.2 (− 0.8, 0.4), and
0.02 (− 0.01, 0.04), respectively. However, costs for pri-
mary closure were 2083 (1410, 2756) cheaper than DPC
($60 USD).
The authors showed that superficial SSI rates for the
primary closure group were slightly lower than the de-
layed group, even if there is no statistical significance.
Costs were significantly lower for the primary closure
group.
Recently, Tang et al. [135] published a meta-analysis
about the benefits of a delayed primary closure over
primary closure of a surgical incision in contaminated
abdominal surgery.
Of the 12 studies included in the analysis, 5 were
from third world countries (i.e., India and Pakistan),
and all of these demonstrated an improvement in the
SSI rate with delayed primary closure. When the
fixed-effect model was used, compared with primary
closure, SSI was significantly reduced in delayed pri-
mary closure with a risk ratio of 0.64 (0.51–0.79)
(P < 0.0001), and a significant difference in LOS be-
tween delayed primary closure and primary closure
was also identified with a mean difference of 0.39
(0.17–0.60) (P = 0.0004). Although the random-effect
model was used, no significant difference in SSI be-
tween delayed and primary closure was observed with
a risk ratio of 0.65 (0.38–1.12) (P = 0.12), and no sig-
nificant difference in LOS with a mean difference of
1.19 (− 1.03 to 3.41) (P = 0.29).
The authors suggested that delayed primary closure
may be the preferable choice in contaminated abdom-
inal surgeries, especially in patients with a high risk
of infection, and particularly in resource-constrained
environments, even if more high-quality studies are
needed to provide clear evidence.
When should additional antibiotic doses be administered
intraoperatively?
Statement 13: Optimal knowledge and use of the
pharmacokinetic/pharmacodynamic characteristics of
antibiotics are important to evaluate when additional
antibiotic doses should be administered intraoperatively in
patients with intra-abdominal infections undergoing
emergency surgery (GoR 1C).
Optimal use of the pharmacokinetic/pharmacodynamic
characteristics of antibiotics is helpful to evaluate when
additional antibiotic doses should be administered intra-
operatively in patients with intra-abdominal infections
undergoing emergency surgery.
Antibiotics should be used after a treatable intra-
abdominal infection (IAI) has been recognized or there
is a high degree of suspicion of infection. Initial anti-
microbial therapy for patients with IAI should be
prompt because especially critically ill patients need im-
mediate treatment. It may be interesting to evaluate
when additional antibiotic doses should be administered
intraoperatively in patients with intra-abdominal infec-
tions undergoing emergency surgery.
To define how to administrate antibiotics in pa-
tients with IAIs, it is necessary to know the pharma-
cokinetic/pharmacodynamic relationship of antibiotics.
Knowledge of the pharmacokinetic and pharmacody-
namic antibiotic properties may provide a more ra-
tional determination of optimal dosing regimens in
terms of the dose and the dosing interval [136].
Antibiotic pharmacodynamics integrates the complex
relationship between organism susceptibility and patient
pharmacokinetics. Pharmacokinetics describes the fun-
damental processes of absorption, distribution, metabol-
ism, and elimination and the resulting concentration-
versus-time profile of an agent administered in vivo. The
achievement of appropriate target site concentrations of
antibiotics is essential to eradicate the pathogens [136].
Suboptimal target site concentrations may have import-
ant clinical implications and may explain therapeutic
failures, in particular, for bacteria for which in vitro
MICs are high. During the operation, target site concen-
trations should remain steadily optimal.
Dosing frequency is related to the concept of time-
dependent versus concentration-dependent killing.
Beta-lactam agents exhibit time-dependent activity
and exert optimal bactericidal activity when drug con-
centrations are maintained above the MIC [137].
Therefore, the serum concentration must exceed the
MIC for the appropriate duration of the dosing
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interval. Higher-frequency dosing, prolonged infu-
sions, and continuous infusions have been utilized to
achieve this effect. It is well known that for beta-
lactams, prolonged or continuous infusions have been
advocated to maximize the time that the drug con-
centration exceeds the MIC, whereas high peak con-
centrations are not beneficial. This concept should be
extended also to patients undergoing an emergency
operation and higher-frequency dosing, prolonged in-
fusions, and continuous infusions should be suggested
also in the operatory room.
In contrast, antibiotics such as aminoglycosides exhibit
concentration-dependent activity and should be admin-
istered in a once-daily manner (or with the least possible
number of daily administrations) to achieve high peak
plasma concentrations [137].
With these agents, the peak serum concentration, and
not the time the concentration remains above the MIC,
is more closely associated with efficacy. In these patients,
additional doses are not necessary during operation.
Conclusions
We conceived this position paper to offer an extensive
overview of available evidence regarding OR prevention
of surgical site infection in emergency surgery as a po-
tential addendum to WSES guidelines on the manage-
ment of intra-abdominal infections.
The use of triclosan-coated suture significantly reduces
SSI prevalence compared with the non-coated sutures.
The use of wound protectors has protective effects in
reducing incisional SSI, in particular, the use of dual-
ring constructed wound protectors appears to be super-
ior to single-ring devices in preventing SSI.
The application of negative-pressure wound therapy in
preventing SSI may be effective in reducing postopera-
tive wound complications and it may be an option to
take into consideration especially in patients with a high
risk of infection.
Intraoperative normothermia decreases the rate of SSI,
and the use of active warming devices in the operating
room is useful to keep normothermia.
Perioperative supplemental oxygenation does not re-
duce SSI.
There is no strong evidence that delayed primary skin
closure may reduce the incidence of SSI but it may be a
valid option to primary skin closure in highly contami-
nated or “dirty” abdominal operations, especially in
patients at high risk of infection.
The optimal knowledge and use of the pharmacoki-
netic/pharmacodynamic characteristics of antibiotics
are important to evaluate when additional antibiotic
doses should be administered intraoperatively in pa-
tients with intra-abdominal infections undergoing
emergency surgery.
Appendix 1
Key words’ list for literature searching:
 “surgical incision” and “closure”“suture” and
“surgical site infection”
 “irrigation” and “incisional wound”;
 “wound protector” and “surgical site infection”;
 “dual ring” and “wound protector” and “wound
infection”;
 “incisional drape” and “wound infection”;
 “drainage” and “subcutaneous” and “surgical
incision”;
 “gloves” and “surgical site infection”;
 “negative pressure wound therapy”and wound
infection” and surgical incision”;
 “normothermia” and “surgical site infection” and
warming device”;
 “antibiotics” and “surgical wound infection” and
“prevention”;
 “hyperoxia/hyperoxigenation”and “surgical site
infection”;
 “timing skin closure” and “early” and “delayed” and
“wound infection” and “dirty surgical incision”.
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